Amsacrine

CHEMBL43 Phase 4 Aprovado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
393.5 g/mol
LogP
4.0
Phase
4

A chemotherapy agent that inhibits an enzyme called topoisomerase II, which cancer cells need to unwind and copy their DNA, leading to strand breaks and cell death. It is used in the treatment of certain leukemias.

Peso Molecular

393,5000 g/mol

LogP

4,00

TPSA

88,70 Ų

Regra dos 5 de Lipinski

Aprovado

Áreas Terapêuticas

Mecanismo de Ação

Inhibits DNA topoisomerase, preventing the relaxation of supercoiled DNA during replication and transcription. This causes DNA strand breaks and triggers apoptosis in rapidly dividing cells.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mecanismo

Inhibits DNA topoisomerase, preventing the relaxation of supercoiled DNA during replication and transcription. This causes DNA strand breaks and triggers apoptosis in rapidly dividing cells.

Estrutura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

COc1cc(NS(C)(=O)=O)ccc1Nc1c2ccccc2nc2ccccc12

InChI

InChI=1S/C21H19N3O3S/c1-27-20-13-14(24-28(2,25)26)11-12-19(20)23-21-15-7-3-5-9-17(15)22-18-10-6-4-8-16(18)21/h3-13,24H,1-2H3,(H,22,23)

Molecular Formula

C21H19N3O3S

HBD / HBA

2 / 6

Ligações Rotacionáveis

5

Átomos Pesados

28

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

A chemotherapy agent that inhibits an enzyme called topoisomerase II, which cancer cells need to unwind and copy their DNA, leading to strand breaks and cell death. It is used in the treatment of certain leukemias.

Inhibits DNA topoisomerase, preventing the relaxation of supercoiled DNA during replication and transcription. This causes DNA strand breaks and triggers apoptosis in rapidly dividing cells.

Yes, Amsacrine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL43. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 2179. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.